Log in to save to my catalogue

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be96c977e54a4450a2f09f1313406618

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

About this item

Full title

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (2), p.273

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The human epidermal growth factor receptor (EGFR) is closely related to several cancer-promoting processes and overexpressed on a variety of tumor types, rendering it an important target structure for the imaging and therapy of several malignancies. To date, approaches to develop peptidic radioligands able to specifically address and visualize EGFR...

Alternative Titles

Full title

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_be96c977e54a4450a2f09f1313406618

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be96c977e54a4450a2f09f1313406618

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph16020273

How to access this item